The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate
Open accessAbstract
The conservation of positively charged residues in the N terminus of the hepatitis C virus (HCV) envelope glycoprotein E2 suggests an interaction of the viral envelope with cell surface glycosaminoglycans. Using recombinant envelope glycoprotein E2 and virus-like particles as ligands for cellular binding, we demonstrate that cell surface heparan sulfate proteoglycans (HSPG) play an important role in mediating HCV envelope-target cell interaction. Heparin and liver-derived highly sulfated heparan sulfate but not other soluble glycosaminoglycans inhibited cellular binding and entry of virus-like particles in a dose-dependent manner. Degradation of cell surface heparan sulfate by pretreatment with heparinases resulted in a marked reduction of viral envelope protein binding. Surface plasmon resonance analysis demonstrated a high affinity interaction (KD 5.2 x 10-9 m) of E2 with heparin, a structural homologue of highly sulfated heparan sulfate. Deletion of E2 hypervariable region-1 reduced E2-heparin interaction suggesting that positively charged residues in the N-terminal E2 region play an important role in mediating E2-HSPG binding. In conclusion, our results demonstrate for the first time that cellular binding of HCV envelope requires E2-HSPG interaction. Docking of E2 to cellular HSPG may be the initial step in the interaction between HCV and the cell surface resulting in receptor-mediated entry and initiation of infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 2,973
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,066
Molecular modeling of protein-glycosaminoglycan interactions.
Cardin, A. D., & Weintraub, H. J. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.1.21 · Cited by 1,301
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R., & Vitelli, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf529 · Cited by 1,177
Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
Chen, Y., Maguire, T., Hileman, R. E., Fromm, J. R., Esko, J. D., Linhardt, R. J., & Marks, R. M. (1997) · Nature Medicine · doi:10.1038/nm0897-866 · Cited by 1,063
Self-citationA Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry
Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., Rosenberg, R. D., & Spear, P. G. (1999) · Cell · doi:10.1016/s0092-8674(00)80058-6 · Cited by 1,054
Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor
Agnello, V., Ábel, G., Elfahal, M., Knight, G. B., & Zhang, Q.-X. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12766 · Cited by 974
Hepatitis C virus replication in mice with chimeric human livers
Mercer, D. F., Schiller, D. E., Elliott, J. F., Douglas, D. N., Hao, C., Rinfret, A., Addison, W. R., Fischer, K. P., Churchill, T. A., Lakey, J. R. T., et al. (2001) · Nature Medicine · doi:10.1038/90968 · Cited by 901
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
André, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J. L., Sodoyer, M., Pol, S., Bréchot, C., Paranhos-Baccalà, G., & Lotteau, V. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.6919-6928.2002 · Cited by 690
Replication of hepatitis C virus
Bartenschlager, R., & Lohmann, V. (2000) · Microbiology · doi:10.1099/0022-1317-81-7-1631 · Cited by 611
Human Papillomavirus Infection Requires Cell Surface Heparan Sulfate
Giroglou, T., Florin, L., Schäfer, F., Streeck, R. E., & Sapp, M. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1565-1570.2001 · Cited by 574
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry
Shukla, D., & Spear, P. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13799 · Cited by 567
Flint, M., Maidens, C., Loomis-Price, L. D., Shotton, C., Dubuisson, J., Monk, P., Higginbottom, A., Levy, S., & McKeating, J. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6235-6244.1999 · Cited by 469
Kim, C. W., Goldberger, O. A., Gallo, R. L., & Bernfield, M. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.7.797 · Cited by 426
Hepatitis C Virus Structural Proteins Assemble into Viruslike Particles in Insect Cells
Baumert, T. F., Ito, S., Wong, D. T., & Liang, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3827-3836.1998 · Cited by 397
Self-citationRosa, D., Campagnoli, S., Moretto, C., Guenzi, E., Cousens, L., Chin, M., Dong, C., Weiner, A. J., Lau, J. Y., Choo, Q. L., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1759 · Cited by 344
Optimal therapy of hepatitis C
Di Bisceglie, A. M., & Hoofnagle, J. H. (2002) · Hepatology · doi:10.1002/hep.1840360716 · Cited by 297
van Kuppevelt, T. H., Dennissen, M. A. B. A., van Venrooij, W. J., Hoet, R. M. A., & Veerkamp, J. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12960 · Cited by 264
Self-citationMargalit, H., Fischer, N., & Ben-Sasson, S. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36503-2 · Cited by 247
Heparan Sulfate-Mediated Binding of Infectious Dengue Virus Type 2 and Yellow Fever Virus
Germi, R., Crance, J.-M., Garin, D., Guimet, J., Lortat-Jacob, H., Ruigrok, R. W. H., Zarski, J.-P., & Drouet, E. (2002) · Virology · doi:10.1006/viro.2001.1232 · Cited by 246
Mandl, C. W., Kroschewski, H., Allison, S. L., Kofler, R., Holzmann, H., Meixner, T., & Heinz, F. X. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5627-5637.2001 · Cited by 240
Wünschmann, S., Medh, J. D., Klinzmann, D., Schmidt, W. N., & Stapleton, J. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10055-10062.2000 · Cited by 222
Heparan Sulfate Proteoglycans Initiate Dengue Virus Infection of Hepatocytes
Hilgard, P., & Stockert, R. (2000) · Hepatology · doi:10.1053/jhep.2000.18713 · Cited by 215
Pénin, F., Combet, C., Germanidis, G. S., Frainais, P.-O., Deléage, G., & Pawlotsky, J. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5703-5710.2001 · Cited by 212
Birkmann, A., Mahr, K., Ensser, A., Yağuboğlu, S., Titgemeyer, F., Fleckenstein, B., & Neipel, F. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11583-11593.2001 · Cited by 206
Hepatitis C virus: Detection of intracellular virus particles by electron microscop
Shimizu, Y. K., Feinstone, S. M., Kohara, M., Purcell, R. H., & Yoshikura, H. (1996) · Hepatology · doi:10.1002/hep.510230202 · Cited by 200
TOIDA, T., YOSHIDA, H., TOYODA, H., KOSHIISHI, I., IMANARI, T., HILEMAN, R. E., FROMM, J. R., & LINHARDT, R. J. (1997) · Biochemical Journal · doi:10.1042/bj3220499 · Cited by 173
Self-citationOp De Beeck, A., Montserret, R., Duvet, S., Cocquerel, L., Cacan, R., Barberot, B., Le Maire, M., Penin, F., & Dubuisson, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003003200 · Cited by 165
Saunier, B., Triyatni, M., Ulianich, L., Maruvada, P., Yen, P. M., & Kohn, L. D. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.546-559.2003 · Cited by 161
Clayton, R., Owsianka, A. M., Aitken, J. A., Graham, S. M., Bhella, D., & Patel, A. H. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9562.2002 · Cited by 144
Clayton, R., Owsianka, A. M., Aitken, J. A., Graham, S. M., Bhella, D., & Patel, A. H. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7672-7682.2002 · Cited by 141
Cell Fusion Activity of Hepatitis C Virus Envelope Proteins
Takikawa, S., Ishii, K., Aizaki, H., Suzuki, T., Asakura, H., Matsuura, Y., & Miyamura, T. (2000) · Journal of Virology · doi:10.1128/.74.11.5066-5074.2000 · Cited by 128
Castet, V., Fournier, C., Soulier, A., Brillet, R., Coste, J., Larrey, D. G., Dhumeaux, D., Maurel, P., & Pawlotsky, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8189-8199.2002 · Cited by 120
Marks, R. M., Lu, H., Sundaresan, R., Toida, T., Suzuki, A., Imanari, T., Hernáiz, M. J., & Linhardt, R. J. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000412i · Cited by 119
Self-citationZhang, Y., Hatziioannou, T., Zang, T. M., Braaten, D. C., Luban, J., Goff, S. P., & Bieniasz, P. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.6332-6343.2002 · Cited by 108
The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines
Hamaia, S. W., Li, C., & Allain, J. (2001) · Blood · doi:10.1182/blood.v98.8.2293 · Cited by 95
Wellnitz, S., Klumpp, B., Barth, H., Ito, S., Depla, E., Dubuisson, J., Blum, H. E., & Baumert, T. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1181-1193.2002 · Cited by 95
Self-citationPrimary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection
Zhao, X., Tang, Z.-Y., Klumpp, B., Wolff-Vorbeck, G., Barth, H., Levy, S., von Weizsäcker, F., Blum, H. E., & Baumert, T. F. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13011 · Cited by 91
Self-citationThe role of the hepatitis C virus glycoproteins in infection
Flint, M., & McKeating, J. A. (2000) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(200003/04)10:2<101::aid-rmv268>3.0.co;2-w · Cited by 84
Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection
Zhao, X., Tang, Z.-Y., Klumpp, B., Wolff-Vorbeck, G., Barth, H., Levy, S., von Weizsäcker, F., Blum, H. E., & Baumert, T. F. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213011 · Cited by 76
Self-citationTamura, M., Natori, K., Kobayashi, M., Miyamura, T., & Takeda, N. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11589-11597.2000 · Cited by 65
A Highly Stable Covalent Conjugated Heparin Biochip for Heparin–Protein Interaction Studies
Zhang, F., Fath, M. A., Marks, R. M., & Linhardt, R. J. (2002) · Analytical Biochemistry · doi:10.1006/abio.2002.5617 · Cited by 56
Self-citationToyoda, H., Nagashima, T., Hirata, R., Toida, T., & Imanari, T. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00478-7 · Cited by 52
Self-citationA putative cellular receptor for dengue viruses
Putnak, J. R., Kanesa-thasan, N., & Innis, B. L. (1997) · Nature Medicine · doi:10.1038/nm0897-828 · Cited by 41
Xiang, J., Wünschmann, S., George, S. L., Klinzman, D., Schmidt, W. N., LaBrecque, D. R., & Stapleton, J. T. (2002) · Journal of Medical Virology · doi:10.1002/jmv.10237 · Cited by 39
Volpi, N. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4218 · Cited by 39
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis
Blanchard, E., Belouzard, S., Goueslain, L., Wakita, T., Dubuisson, J., Wychowski, C., & Rouillé, Y. (2006) · Journal of Virology · doi:10.1128/jvi.00024-06 · Cited by 599
Pestka, J. M., Zeisel, M. B., Bläser, E., Schürmann, P., Bartosch, B., Cosset, F.-L., Patel, A. H., Meisel, H., Baumert, J., Viazov, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607026104 · Cited by 564
Self-citationUnderstanding the hepatitis C virus life cycle paves the way for highly effective therapies
Scheel, T. K. H., & Rice, C. M. (2013) · Nature Medicine · doi:10.1038/nm.3248 · Cited by 554
Metadata
- Authors
- Barth, H., Schäfer, C., Adah, M. I., Zhang, F., Linhardt, R. J., Toyoda, H., Kinoshita-Toyoda, A., Toida, T., van Kuppevelt, T. H., Depla, E., von Weizsäcker, F., Blum, H. E., & Baumert, T. F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-10
- Volume
- 278
- Issue
- 42
- Pages
- 41003-41012
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2118320694
- Cited by
- 500
- References
- 48
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.